Media OutReach

SINGAPORE – Media OutReach – 6 April 2022 – Winston Engineering Corporation has announced that it will be launching a new product at the Singapore International Water Week (SIWW) 2022 this year. The pump specialist company plans to unveil its new integrated pumping system, Esybox Max, at one of Asia’s …

SINGAPORE – Media OutReach – 6 April 2022 – Aon plc (NYSE: AON), a leading global professional services firm, has published the 2022 Asia Market Review, Aon’s ninth annual publication on the risk management and mitigation landscape in Asia. The report reveals insights on the key market-shaping forces of 2022 …

Deleted Source link

HONG KONG SAR AND SHANGHAI, CHINA – Media OutReach – 6 April 2022 – The COVID-19 situation continues in many cities on the Mainland, making the pandemic countermeasures more challenging. Hang Lung Properties announced a further injection of RMB 3 million into the “Hang Lung COVID-19 Relief Fund 2.0” in …

HONG KONG SAR – Media OutReach – 6 April 2022 – BEA Union Investment Management Limited (“BEA Union Investment”) is pleased to announce that we are crowned the Provider of the Year (Onshore) 20211 by Benchmark, which translates that we were recognised as one of the top performed fund manager …

1. R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) 2. More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years 3. Human Pharma pipeline acceleration: up to 15 new product launches expected until 2025 …

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches expected until 2025 INGELHEIM, GERMANY – …

· R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) · More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years · Human Pharma pipeline acceleration: up to 15 new product launches expected until 2025 …

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches expected until 2025 INGELHEIM, GERMANY – …

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches expected until 2025 INGELHEIM, GERMANY – …